Fantastic presentation by @AndreaNecchi on KN057 trial! Meaningful data on efficacy & safety aiming to address a ve… https://t.co/yUwHdTWO4Q
See more from Petros Grivas
#GU23: very important data from KN057 trial presented by Dr. Necchi on pembro alone in pts with high-risk BCG-unresponsive Ta or T1 (no CIS): DFS rate, safety profile, qoL/PROs suggest that pembro can be an option in pts who decline or cannot undergo radical cystectomy